Evaluation study of the UCS® Debridement medical device in the treatment of chronic skin lesions

Submitted: November 21, 2023
Accepted: January 10, 2024
Published: April 30, 2024
Abstract Views: 346
PDF: 53
PDF (Italiano): 268
Supplementary materials: 17
Materiali supplementari (Italiano): 39
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

UCS® Debridement is a sterile system for the initial debridement and maintenance of chronic skin lesions and for the cleansing and hydration of the perilesional edges and the entire limb. The system is designed to improve and facilitate the cleansing and mechanical debridement phase. Recommendations for the management of a wound with the presence of biofilm include cleaning, debridement, and application of an appropriate dressing to keep the number of microorganisms to a minimum. The debridement activity should be started and undertaken regularly. The aim of this observational study is to demonstrate the effectiveness of biofilm removal by the medical devices used, reduction of pain during and after the procedure, reduction of operative times, reduction of bleeding, benefits to wound edges of the injury, and improvement of perilesional skin

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. Journal of Wound Care 2017;26:20-5. DOI: https://doi.org/10.12968/jowc.2017.26.1.20
Percival SL. Importance of biofilm formation in surgical infection. British Journal of Surgery 2017;104:e85-94. DOI: https://doi.org/10.1002/bjs.10433
Percival SL, Mayer D, Kirsner RS, et al. Surfactants: role in biofilm management and cellular behaviour. International Wound Journal 2019;16:753-60. DOI: https://doi.org/10.1111/iwj.13093
Sibbald RG, Ayello EA. Fifth Congress of the World Union of Wound Healing Societies 2016 and International Education Focus. Advances in Skin and Wound Care 2017;30:72-82. DOI: https://doi.org/10.1097/01.ASW.0000511882.41458.63
Percival SL, Chen R, Mayer D, Salisbury A-M. Mode of action of poloxamer-based surfactants in wound care and efficacy on biofilms. International Wound Journal 2018;15:749-55. DOI: https://doi.org/10.1111/iwj.12922
Schultz G, Bjarnsholt T, James GA, et al. Consensus guidelines for the diagnosis and treatment of biofilms in chronic non-healing wounds. Wound Repair and Regeneration 2017;25:744-57. DOI: https://doi.org/10.1111/wrr.12590
European Wound Management Association (EWMA). Documento di posizionamento. Gestione delle ferite infette. Disponibile su: https://ewma.org/fileadmin/user_upload/EWMA.org/Position_documents_2002-2008/Italian_pos_doc_2006.pdf

How to Cite

Giacinto, F., Giacinto, E., & Giacinto, M. (2024). Evaluation study of the UCS<sup>®</sup> Debridement medical device in the treatment of chronic skin lesions. Italian Journal of Wound Care, 8(1). https://doi.org/10.4081/ijwc.2024.107